This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Uncategorised Disease
  • /
  • Recombinant factor VIII Fc fusion protein: extende...
Journal

Recombinant factor VIII Fc fusion protein: extended-interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels.

Read time: 1 mins
Published:25th Mar 2020
Author: Shapiro AD, Ragni MV, Kulkarni R, Oldenberg J, Srivastava A, Quon DV et al.
Ref.:J Thromb Haemost. 2014 Nov;12(11):1788-800.
DOI:10.1111/jth.12723.
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest